Gut Barrier Study in Ulcerative Colitis Remission
Part of Digestive system clinical trials.
This study looks at gut barrier function in people with ulcerative colitis who are in remission. It uses a non-invasive liver test to check for subtle changes in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with ulcerative colitis for at least 6 months.
- Your ulcerative colitis is currently in remission (no symptoms) and a stool test shows low inflammation levels.
- You are willing to have a liver stiffness test (FibroScan) done.
- You do not have other liver disease, heavy alcohol use, or other conditions listed in the exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether stool tests, combined with a special camera test of the colon, can help find early signs of colon changes in people who have had ulcerative colitis for a long time. It aims to improve how we monitor for any serious changes like cancer.
This study uses simple breath tests to measure changes in your gut during dietary treatment for ulcerative colitis. It may help doctors understand why some people respond better to dietary changes and guide future treatment decisions.
This study looks at whether early stool tests (fecal immunochemical test and calprotectin) can predict when ulcerative colitis symptoms might return. It is for people who have never taken biologic medications.
This study tests whether using a simple stool test to guide treatment is better than usual care for people with ulcerative colitis in remission. It aims to keep you in remission longer and prevent flare-ups.
This study looks at whether a simple stool test can tell if treatment is healing the gut lining in people with moderate to severe ulcerative colitis who are starting their first biologic medicine. If it works, this test might help doctors adjust treatment earlier.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
Hear when a new Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.